1667 related articles for article (PubMed ID: 24728327)
1. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
[TBL] [Abstract][Full Text] [Related]
2. Novel candidates of pathogenic variants of the BRCA1 and BRCA2 genes from a dataset of 3,552 Japanese whole genomes (3.5KJPNv2).
Tokunaga H; Iida K; Hozawa A; Ogishima S; Watanabe Y; Shigeta S; Shimada M; Yamaguchi-Kabata Y; Tadaka S; Katsuoka F; Ito S; Kumada K; Hamanaka Y; Fuse N; Kinoshita K; Yamamoto M; Yaegashi N; Yasuda J
PLoS One; 2021; 16(1):e0236907. PubMed ID: 33428613
[TBL] [Abstract][Full Text] [Related]
3. Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants.
Rasnic R; Brandes N; Zuk O; Linial M
BMC Cancer; 2019 Aug; 19(1):783. PubMed ID: 31391007
[TBL] [Abstract][Full Text] [Related]
4. Characterization of germline mutations in familial lung cancer from the Chinese population.
Kanwal M; Ding XJ; Ma ZH; Li LW; Wang P; Chen Y; Huang YC; Cao Y
Gene; 2018 Jan; 641():94-104. PubMed ID: 29054765
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Johansson PA; Nathan V; Bourke LM; Palmer JM; Zhang T; Symmons J; Howlie M; Patch AM; Read J; Holland EA; Schmid H; Warrier S; Glasson W; Höiom V; Wadt K; Jönsson G; Olsson H; Ingvar C; Mann G; Brown KM; Hayward NK; Pritchard AL
Melanoma Res; 2019 Oct; 29(5):483-490. PubMed ID: 31464824
[TBL] [Abstract][Full Text] [Related]
6. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
7. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract][Full Text] [Related]
8. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
10. Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study.
Casula M; Paliogiannis P; Ayala F; De Giorgi V; Stanganelli I; Mandalà M; Colombino M; Manca A; Sini MC; Caracò C; Ascierto PA; Satta RR; ; Lissia A; Cossu A; Palmieri G;
BMC Cancer; 2019 Aug; 19(1):772. PubMed ID: 31382929
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
12. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.
Link DC; Schuettpelz LG; Shen D; Wang J; Walter MJ; Kulkarni S; Payton JE; Ivanovich J; Goodfellow PJ; Le Beau M; Koboldt DC; Dooling DJ; Fulton RS; Bender RH; Fulton LL; Delehaunty KD; Fronick CC; Appelbaum EL; Schmidt H; Abbott R; O'Laughlin M; Chen K; McLellan MD; Varghese N; Nagarajan R; Heath S; Graubert TA; Ding L; Ley TJ; Zambetti GP; Wilson RK; Mardis ER
JAMA; 2011 Apr; 305(15):1568-76. PubMed ID: 21505135
[TBL] [Abstract][Full Text] [Related]
14. Ancestry and frequency of genetic variants in the general population are confounders in the characterization of germline variants linked to cancer.
Bobyn A; Zarrei M; Zhu Y; Hoffman M; Brenner D; Resnick AC; Scherer SW; Gallo M
BMC Med Genet; 2020 May; 21(1):92. PubMed ID: 32375678
[TBL] [Abstract][Full Text] [Related]
15. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
Johnston JJ; Rubinstein WS; Facio FM; Ng D; Singh LN; Teer JK; Mullikin JC; Biesecker LG
Am J Hum Genet; 2012 Jul; 91(1):97-108. PubMed ID: 22703879
[TBL] [Abstract][Full Text] [Related]
16. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families.
Guénard F; Labrie Y; Ouellette G; Beauparlant CJ; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Pichette R; Plante M; Durocher F;
Fam Cancer; 2007; 6(4):483-90. PubMed ID: 17636424
[TBL] [Abstract][Full Text] [Related]
18. Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients.
Lee DS; Yoon SY; Looi LM; Kang P; Kang IN; Sivanandan K; Ariffin H; Thong MK; Chin KF; Mohd Taib NA; Yip CH; Teo SH
Breast Cancer Res; 2012 Apr; 14(2):R66. PubMed ID: 22507745
[TBL] [Abstract][Full Text] [Related]
19. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria.
Wang S; Pitt JJ; Zheng Y; Yoshimatsu TF; Gao G; Sanni A; Oluwasola O; Ajani M; Fitzgerald D; Odetunde A; Khramtsova G; Hurley I; Popoola A; Falusi A; Ogundiran T; Obafunwa J; Ojengbede O; Ibrahim N; Barretina J; White KP; Huo D; Olopade OI
Int J Cancer; 2019 Dec; 145(12):3321-3333. PubMed ID: 31173346
[TBL] [Abstract][Full Text] [Related]
20. The Personal Genome Project Canada: findings from whole genome sequences of the inaugural 56 participants.
Reuter MS; Walker S; Thiruvahindrapuram B; Whitney J; Cohn I; Sondheimer N; Yuen RKC; Trost B; Paton TA; Pereira SL; Herbrick JA; Wintle RF; Merico D; Howe J; MacDonald JR; Lu C; Nalpathamkalam T; Sung WWL; Wang Z; Patel RV; Pellecchia G; Wei J; Strug LJ; Bell S; Kellam B; Mahtani MM; Bassett AS; Bombard Y; Weksberg R; Shuman C; Cohn RD; Stavropoulos DJ; Bowdin S; Hildebrandt MR; Wei W; Romm A; Pasceri P; Ellis J; Ray P; Meyn MS; Monfared N; Hosseini SM; Joseph-George AM; Keeley FW; Cook RA; Fiume M; Lee HC; Marshall CR; Davies J; Hazell A; Buchanan JA; Szego MJ; Scherer SW
CMAJ; 2018 Feb; 190(5):E126-E136. PubMed ID: 29431110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
